CN Patent

CN103536688A — 抗过敏性炎症滴剂

Assigned to NINGXIA RUISHI EYE INSTITUTE · Expires 2014-01-29 · 12y expired

What this patent protects

一种抗过敏性炎症滴剂,由组合药液组成,组合药液的成份包括色甘酸钠、鱼腥草、庆大霉素、氮卓斯汀、阿托品,其中,色甘酸钠的剂量为2~3份,鱼腥草的剂量为1~2份,庆大霉素的剂量为1~2份,氮卓斯汀的剂量为0.2~0.5份,阿托品的剂量为0.2~0.5份。本发明的优点和积极效果为:一是在现有成熟药物上的集成创新;二是开辟了药物协同治疗的新路径;三是多种药物集成发挥协同作用,药效显著,控制疾病迅速有效;四是一支制剂内集多种药物不同功效于一体,使单个药量减少,整体药效提高,达到事半功倍的效果,疗效十分满意;五是原材料取材方便,工艺简单,无需制药,有利于环保,还节省…

USPTO Abstract

一种抗过敏性炎症滴剂,由组合药液组成,组合药液的成份包括色甘酸钠、鱼腥草、庆大霉素、氮卓斯汀、阿托品,其中,色甘酸钠的剂量为2~3份,鱼腥草的剂量为1~2份,庆大霉素的剂量为1~2份,氮卓斯汀的剂量为0.2~0.5份,阿托品的剂量为0.2~0.5份。本发明的优点和积极效果为:一是在现有成熟药物上的集成创新;二是开辟了药物协同治疗的新路径;三是多种药物集成发挥协同作用,药效显著,控制疾病迅速有效;四是一支制剂内集多种药物不同功效于一体,使单个药量减少,整体药效提高,达到事半功倍的效果,疗效十分满意;五是原材料取材方便,工艺简单,无需制药,有利于环保,还节省能源,大大降低劳动强度。

Drugs covered by this patent

Patent Metadata

Patent number
CN103536688A
Jurisdiction
CN
Classification
Expires
2014-01-29
Drug substance claim
No
Drug product claim
No
Assignee
NINGXIA RUISHI EYE INSTITUTE
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.